Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia
A terminated clinical trial evaluated the safety of risperidone in obese or overweight patients with schizophrenia or schizoaffective disord…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
This clinical trial update reports the completion of a Phase 3 study assessing how long it takes patients to relapse after switching from an…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine [Phase 1]
A Phase 1 study update assessing the effects of extended-release paliperidone and quetiapine on QT and QTc intervals in patients with schizo…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection [Phase 3]
A Phase 3 study evaluated how useful a Risperdal Consta treatment guidebook is for doctors when adults with schizophrenia or schizoaffective…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder [Phase 3]
A Phase 3 clinical trial evaluated monthly injections of risperidone for efficacy and safety in adults with schizophrenia or schizoaffective…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients. [Phase 3]
Phase 3 long-term safety study of long-acting injectable risperidone in schizophrenia or schizoaffective disorder patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder. [Phase 3]
Update on long-term safety results from a Phase 3 study of a long-acting injectable risperidone in adults with schizophrenia or schizoaffect…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial assessing the effects of risperidone and olanzapine on blood glucose in patients with schizophrenia or schizoaffective disorde…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis [Phase 4]
This document reports the completion of a Phase 4 trial evaluating risperidone long-acting injectable in early psychosis.
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Study of Amantadine for Weight Stabilization During Olanzapine Treatment [Phase 1]
A Phase 1 study evaluating whether amantadine can stabilize weight during olanzapine treatment has been completed.
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Pfizer completed a Phase 3 trial evaluating varenicline (Chantix) for smoking cessation in patients with schizophrenia or schizoaffective di…
-
CLINICAL_TRIALS research · 2011-03-28Clinical Trial Update: Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia
Clinical trial update examining how gene polymorphisms affect metabolic features in clozapine-treated patients with schizophrenia.
-
CLINICAL_TRIALS research · 2011-03-23Clinical Trial Update: Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
A Phase 3 trial is evaluating minocycline, acetylsalicylic acid, or pramipexole versus placebo in patients with schizophrenia or schizoaffec…
-
CLINICAL_TRIALS research · 2011-01-20Clinical Trial Update: Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder [Phase 3]
Phase 3 study evaluating raloxifene for schizophrenia and schizoaffective disorder; the current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants [Phase 2, Phase 3]
An update on Phase 2 and Phase 3 trials evaluating whether omega-3 fatty acid EPA, combined with antioxidants, can treat schizophrenia and r…
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder [Phase 4]
Phase 4 trial update on the efficacy of quetiapine for patients with schizophrenia and comorbid substance use disorder; results were posted …
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia [Phase 4]
Phase 4 trial evaluating pregnenolone augmentation in patients with recent-onset schizophrenia; the study status is completed, but no result…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Schizophrenic Patients Taking Part in Integrated Care Program
The AstraZeneca-sponsored clinical trial involving schizophrenia and related psychotic disorders has been terminated.
-
CLINICAL_TRIALS research · 2010-12-10Clinical Trial Update: Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia
A completed AstraZeneca-sponsored trial evaluated the validity of the Spanish version of the Subjective Well-being Under Neuroleptics Scale …
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia [Phase 4]
Phase 4 trial evaluating the efficacy and safety of adding escitalopram to ongoing treatment in treatment-resistant schizophrenia and schizo…
-
FDA approval · 2010-12-01FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for risperidone (RISPERDAL) from Janssen Pharmaceuticals, Inc., resulting in changes to its labe…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 study evaluating a long-acting injectable risperidone for schizophrenia (and schizoaffective disorder considerations in the title) h…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Polypharmacy in Clozapine-resistant Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating polypharmacy in clozapine-resistant schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-09Clinical Trial Update: Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis [NA]
A completed clinical trial evaluating Acceptance and Commitment Therapy for distress following psychosis has been reported. The study, spons…
-
CLINICAL_TRIALS trial_result · 2010-10-18Clinical Trial Update: RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
This document reports a completed post-authorization safety study (RiSPECT) evaluating the safety and effectiveness of risperidone used in r…